Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 79,571.0 | 80,118.0 | 68,397.0 | 44,998.0 | 43,310.0 | 40,604.0 | 37,490.0 | 32,467.0 |
Revenue growth | -0.7% | 17.1% | 52.0% | 3.9% | 6.7% | 8.3% | 15.5% | 9.8% |
Cost of goods sold | 37,293.0 | 36,605.0 | 28,266.0 | 18,521.0 | 18,354.0 | 17,708.0 | 16,550.0 | 14,898.0 |
Gross profit | 42,278.0 | 43,513.0 | 40,131.0 | 26,477.0 | 24,956.0 | 22,896.0 | 20,940.0 | 17,569.0 |
Gross margin | 53.1% | 54.3% | 58.7% | 58.8% | 57.6% | 56.4% | 55.9% | 54.1% |
Selling, general and administrative | 21,607.0 | 20,238.0 | 18,926.0 | 14,139.0 | 13,161.0 | 12,259.0 | 11,378.0 | 10,189.0 |
EBITA | 9,307.0 | 8,192.0 | 8,254.0 | 5,804.0 | 5,433.0 | 4,816.0 | 3,539.0 | 2,968.0 |
EBITA margin | 11.7% | 10.2% | 12.1% | 12.9% | 12.5% | 11.9% | 9.4% | 9.1% |
Amortization of intangibles | 1,200.0 | 1,300.0 | 1,200.0 | 82.0 | 124.0 | 163.0 | 220.0 | 276.0 |
EBIT | 8,107.0 | 6,892.0 | 7,054.0 | 5,722.0 | 5,309.0 | 4,653.0 | 3,319.0 | 2,692.0 |
EBIT margin | 10.2% | 8.6% | 10.3% | 12.7% | 12.3% | 11.5% | 8.9% | 8.3% |
Pre-tax income | 3,146.0 | 3,351.0 | 3,530.0 | 4,603.0 | 3,917.0 | 3,161.0 | 2,327.0 | 978.0 |
Income taxes | 556.0 | 327.0 | 786.0 | 1,135.0 | 1,029.0 | -1,375.0 | 867.0 | 245.0 |
Tax rate | 17.7% | 9.8% | 22.3% | 24.7% | 26.3% | | 37.3% | 25.1% |
Earnings from continuing ops | 2,590.0 | 3,024.0 | 2,424.0 | 3,468.0 | 2,888.0 | 4,481.0 | 1,405.0 | 678.0 |
Earnings from discontinued ops | | | 320.0 | | | | | |
Net income | 2,590.0 | 3,024.0 | 2,744.0 | 3,468.0 | 2,888.0 | 4,481.0 | 1,405.0 | 678.0 |
Net margin | 3.3% | 3.8% | 4.0% | 7.7% | 6.7% | 11.0% | 3.7% | 2.1% |
|
Diluted EPS | $2.06 | $2.41 | $2.10 | $4.02 | $3.36 | $5.14 | $1.69 | $0.82 |
Shares outstanding (diluted) | 1,255.4 | 1,254.8 | 1,154.7 | 863.4 | 858.3 | 871.8 | 833.1 | 822.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|